Bangaru, Sandhya
Zhang, Heng
Gilchuk, Iuliia M.
Voss, Thomas G.
Irving, Ryan P.
Gilchuk, Pavlo
Matta, Pranathi
Zhu, Xueyong
Lang, Shanshan
Nieusma, Travis
Richt, Juergen A.
Albrecht, Randy A.
Vanderven, Hillary A.
Bombardi, Robin
Kent, Stephen J.
Ward, Andrew B.
Wilson, Ian A. http://orcid.org/0000-0002-6469-2419
Crowe, James E. Jr. http://orcid.org/0000-0002-0049-1079
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI117905, HHSN272201400024C)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA068485)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR000445)
Article History
Received: 17 July 2017
Accepted: 16 May 2018
First Online: 10 July 2018
Competing interests
: J.E.C. has served as a consultant for Takeda Vaccines, Sanofi Pasteur, Pfizer, and Novavax, is on the Scientific Advisory Boards of CompuVax, GigaGen, Meissa Vaccines, PaxVax, and is Founder of IDBiologics, Inc. The remaining authors declare no competing interests.